Liver disease after bone marrow transplantation

Area of Science:

• Hepatology
• Hematology
• Immunology

Background:

• Liver dysfunction is a common complication following bone marrow transplantation (BMT).
• The specific contributions of graft-versus-host disease (GVHD), infection, radiation, and medications to post-BMT liver injury remain unclear.
• Understanding these factors is crucial for improving patient outcomes after BMT.

Purpose of the Study:

• To investigate the incidence and severity of liver dysfunction post-BMT.
• To determine the relationship between liver status, GVHD, and other potential causes of liver injury.
• To identify predictive markers for survival and liver disease development after BMT.

Main Methods:

• Prospective study of liver function tests and clinical status in 43 consecutive BMT patients.
• Correlation of liver test abnormalities with survival, GVHD, infections, and treatment regimens.
• Histopathological examination of liver biopsies, focusing on bile duct atypia and GVHD markers.

Main Results:

• Pre-transplant liver abnormalities did not impact survival. Post-transplant, 83% of patients showed abnormal liver tests within 50 days.
• Elevated alanine transaminase levels were significantly higher in non-survivors, serving as an early survival predictor.
• Severe liver disease was consistently linked to GVHD; bile duct atypia was a key histological indicator. Chemotherapy and conditioning regimens were implicated in hepatic veno-occlusive disease.

Conclusions:

• Graft-versus-host disease is a primary driver of severe liver dysfunction post-BMT.
• Alanine transaminase elevation is a valuable early indicator of prognosis.
• Chemotherapy and conditioning regimens are significant contributors to hepatic veno-occlusive disease development.